Alzheimer's disease

Comment

Find out how pharma is fighting respiratory illnesses in the latest Pharma Technology Focus

Pharma Technology Focus is now available on all devices. Read it for free here We look into the safety issues associated…

Features

Expert Insights: Another Failure for BACE1 Drugs Raises Questions about Alzheimer’s Disease Treatments

Johnson & Johnson’s Janssen division has decided to halt the Phase II–III EARLY clinical trial (NCT02569398) of its Alzheimer’s disease…